Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a Phase 1, randomized, double-blind, placebo-controlled single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of VK2735 in healthy adults and otherwise healthy adults who have an increased body mass index (BMI).
Epistemonikos ID: 2a9517b59f181f2cff0a893412981a70edc69ab4
First added on: May 10, 2024